Case Management for HIV
(CM2 Trial)
Trial Summary
What is the purpose of this trial?
The overall goal of this study is to test whether dyadic and focused case management will (1) improve financial wellbeing, (2) improve access to food, (3) increase linkage and retention rates for individuals living with HIV or those taking PrEP (PrEP persistence), and (4) increase the proportion of individuals living with HIV who are virally suppressed (viral suppression) when compared to routine Ryan White Non-Medical Case Management.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It is best to consult with the trial coordinators for specific guidance.
What data supports the effectiveness of the treatment Dyadic Case Management, Focused Case Management, Dyadic Intervention for HIV?
Research shows that case management for HIV patients can lead to better health outcomes, such as increased use of HIV medications, improved engagement in HIV care, and reduced risky behaviors like unprotected sex. These findings suggest that case management can be an effective treatment approach for improving the health and well-being of individuals living with HIV.12345
Is case management for HIV generally safe for humans?
How is the Dyadic Case Management treatment for HIV different from other treatments?
Dyadic Case Management for HIV is unique because it focuses on linking patients with coordinated health and social services, addressing unmet needs, and improving health outcomes by reducing risky behaviors and enhancing engagement in care. This approach is particularly beneficial for populations with specific challenges, such as substance users and the homeless, by providing personalized support and empowerment.12348
Research Team
John A Schneider, MD, MPH
Principal Investigator
University of Chicago
Eligibility Criteria
This trial is for Black/African American individuals who are either living with HIV or vulnerable to it, have had a gap in HIV or PrEP care, and face financial or food insecurity. Eligible participants include cis-gender men with male partners in the past year, gender-diverse persons, and cis-gender women prescribed PrEP or with an STI history.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive dyadic case management focused on financial wellness, food security, and linkage to care
Follow-up
Participants are monitored for outcomes such as viral suppression, food security, and financial wellbeing
Treatment Details
Interventions
- Dyadic Case Management
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Chicago
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator